FDA Investigator Katherine D Adams
Katherine D Adams has conducted inspections on 10 sites in 5 countries as of 08 Jul 2019. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
10
Last Inspection Date:
08 Jul 2019
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Malaysia,
India,
Korea (Republic of),
Canada
FDA Investigators that have inspected at least one site in common with Katherine D Adams:
Abdur Rafay Shareef,
Ademola O Daramola,
Alan P Kurtzberg,
Althea A Williams,
Amber G Wardwell,
Andrew M Barlow,
Anjali Shukla, PhD,
Anthony C Warchut,
Anthony W Thomas,
Arie C Menachem,
Binh T Nguyen,
Brenda P King,
Carla C Cummins,
Carla C Tuite,
Carla J Lundi,
Cassandra L Abellard,
Christopher S Keating,
Daniel J Lahar,
David A Oluwo,
Dell S Moller,
Donna J Clevenger,
Eileen A Liu,
Elizabeth B Griffin,
Ellen P Madigan,
Felix Maldonado,
Gary J Hagan,
Ginger M Sykes,
Hamet M Toure, PharmD MPH,
Holly Brevig,
Ivis L Negron,
Ivy E Sweeney,
James H Tanner,
Jie He,
Joel D Hustedt,
John A Sciacchitano,
Jonathan G Matrisciano,
Jose Acruz Gonzalez,
José E Meléndez,
Joshua J Silvestri,
Joshua P Wireman,
Katie L Korchinski,
Kenneth H Williams,
Kenneth M Gordon,
Kevin A Gonzalez,
Kevin D Kallander,
Kham Phommachanh,
Kristin M Abaonza,
LCDR Debra Emerson,
Libia M Lugo,
Linda F Murphy,
Linda K Cline,
Lydia I Rosas Marty,
Maryam Tabatabaie,
Matthew C Watson,
Maya M Davis,
Megan A Haggerty,
Meyer J Slobotsky,
Michael A Charles,
Michael P Anthony,
Michael P Sheehan,
Michael R Goga,
Michael R Klapal,
Nancy A Saxenian Emmons,
Nancy L Rolli,
Paraluman S Leonin,
Parul M Patel,
Patty P Kaewussdangkul,
Paul L Bellamy,
Phillip E Mclaughlin,
Raeann R Wu,
Ramon E Martinez,
Rebecca E Dombrowski,
Richard Ledwidge (nmi), PhD,
Robert J Martin,
Roger F Zabinski,
Rong Guo,
Rory K Geyer,
Sandra A Boyd,
Sandra P White,
Santos E Camara,
Seth A Mailhot,
Sharon K Thoma, PharmD,
Shawn E Larson,
Stacey S Degarmo,
Susan M Jackson,
Susanna E Ford,
Thomas J Arista,
Todd M Stankewicz,
Towanda L Terrell,
Ucheabuchi Cchudi Nwankwor,
Valentino Fiorella,
Vidya B Pai,
Wayne E Seifert,
Yetao Jin, PhD,
Youkeun Kim,
Yumi J Hiramine
Katherine D Adams's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2014 | FDA 483 | Millennium Pharmaceuticals, Inc. - Form 483, 2014-08-15 |
July, 2019 | FDA 483 | BIOCON SDN.BHD. - Form 483, 2019-07-05 |
July, 2019 | FDA 483 | fmg Co.Ltd - Form 483, 2019-07-12 |
February, 2018 | FDA 483 | Galentic Pharma (India) Private Limited - Form 483, 2018-02-21 |
February, 2017 | FDA 483 | Gland Pharma Limited - Form 483, 2017-02-03 |
July, 2016 | FDA 483 | Curia Massachusetts, Inc. - Form 483, 2016-07-13 |
August, 2018 | FDA 483 | Resilience Biotechnologies, Inc. - Form 483, 2018-08-08 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more